Allstate (NYSE:ALL - Get Free Report)'s stock had its "buy (b)" rating restated by research analysts at Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.
ALL has been the subject of a number of other research reports. Wolfe Research raised shares of Allstate to a "strong-buy" rating in a research note on Tuesday, September 16th. Cantor Fitzgerald raised shares of Allstate to a "hold" rating in a research note on Wednesday, August 13th. Wall Street Zen raised shares of Allstate from a "hold" rating to a "buy" rating in a research note on Tuesday, August 5th. Keefe, Bruyette & Woods upped their price objective on shares of Allstate from $237.00 to $246.00 and gave the company an "outperform" rating in a research note on Wednesday, August 6th. Finally, BMO Capital Markets upped their price objective on shares of Allstate from $230.00 to $235.00 and gave the company an "outperform" rating in a research note on Wednesday, August 20th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Allstate has an average rating of "Moderate Buy" and a consensus price target of $232.50.
Read Our Latest Analysis on Allstate
Allstate Trading Up 1.0%
NYSE:ALL traded up $2.22 on Wednesday, reaching $214.01. The stock had a trading volume of 248,161 shares, compared to its average volume of 1,666,497. The company has a market cap of $56.39 billion, a price-to-earnings ratio of 10.06, a P/E/G ratio of 0.81 and a beta of 0.38. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43. The firm's fifty day moving average is $205.41 and its two-hundred day moving average is $201.05. Allstate has a 12-month low of $176.00 and a 12-month high of $215.70.
Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.20 by $2.74. The company had revenue of $15.05 billion for the quarter, compared to analyst estimates of $16.59 billion. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The firm's quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.61 EPS. Equities analysts expect that Allstate will post 18.74 EPS for the current fiscal year.
Institutional Trading of Allstate
Large investors have recently bought and sold shares of the company. Arlington Trust Co LLC grew its position in Allstate by 261.8% in the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider's stock valued at $25,000 after acquiring an additional 89 shares in the last quarter. Hughes Financial Services LLC acquired a new stake in shares of Allstate during the first quarter worth approximately $28,000. Clearstead Trust LLC grew its position in shares of Allstate by 3,800.0% during the second quarter. Clearstead Trust LLC now owns 156 shares of the insurance provider's stock worth $31,000 after buying an additional 152 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its position in shares of Allstate by 315.0% during the second quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider's stock worth $33,000 after buying an additional 126 shares in the last quarter. Finally, Hilltop National Bank acquired a new stake in shares of Allstate during the second quarter worth approximately $34,000. Institutional investors and hedge funds own 76.47% of the company's stock.
Allstate Company Profile
(
Get Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.